The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
B cell regulation in cancer and anti-tumor immunity
Open accessAbstract
The balance between immune effector cells and immunosuppressive cells and how this regulates the tumor microenvironment has been well described. A significant contribution of immune regulatory cells, including regulatory T cells, to tumor progression has been widely reported. An emerging body of evidence has recently recognized a role for B cells in modulating the immune response to tumors and lymphoid malignancies. Regulatory B cells (Bregs) are a newly designated subset of B cells that have been shown to play a pivotal role in regulating immune responses involved in inflammation, autoimmunity and, more recently, cancer. Bregs can suppress diverse cell subtypes, including T cells, through the secretion of anti-inflammatory mediators, such as IL-10, and can facilitate the conversion of T cells to regulatory T cells, thus attenuating anti-tumor immune responses. Similar B-cell subpopulations have been reported to be recruited to the tumor but to acquire their immunosuppressive properties within the tumor bed and thereby attenuate anti-tumor immune responses. However, despite a pivotal role for Bregs in promoting inflammation and carcinogenesis, the phenotypic diversity of the cell surface markers that are unique to Bregs remains unclear in mice and humans. In this review, we summarize the characteristics of Bregs and review our current knowledge of Bregs and their inhibition of anti-tumor immune responses in murine tumor models and cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Li, Y., Liang, N., Qin, Y., Ma, D., Huang, C., Liu, L., & Li, S. (2016) · Tumor Biology · doi:10.1007/s13277-016-5458-3 · Cited by 57
RetractedLiu, J., Wang, H., Yu, Q., Zheng, S., Jiang, Y., Liu, Y., Yuan, G., & Qiu, L. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.10.015 · Cited by 49
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
B cells regulate autoimmunity by provision of IL-10
Fillatreau, S., Sweenie, C. H., McGeachy, M. J., Gray, D., & Anderton, S. M. (2002) · Nature Immunology · doi:10.1038/ni833 · Cited by 1,647
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
von Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Regulatory B Cells: Origin, Phenotype, and Function
Rosser, E. C., & Mauri, C. (2015) · Immunity · doi:10.1016/j.immuni.2015.04.005 · Cited by 1,455
B lymphocytes: how they develop and function
LeBien, T. W., & Tedder, T. F. (2008) · Blood · doi:10.1182/blood-2008-02-078071 · Cited by 1,400
Yanaba, K., Bouaziz, J.-D., Haas, K. M., Poe, J. C., Fujimoto, M., & Tedder, T. F. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.017 · Cited by 1,238
Iwata, Y., Matsushita, T., Horikawa, M., DiLillo, D. J., Yanaba, K., Venturi, G. M., Szabolcs, P. M., Bernstein, S. H., Magro, C. M., Williams, A. D., et al. (2011) · Blood · doi:10.1182/blood-2010-07-294249 · Cited by 1,104
Cancer immunoediting from immune surveillance to immune escape
Kim, R., Emi, M., & Tanabe, K. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02587.x · Cited by 1,074
Shen, P., Roch, T., Lampropoulou, V., O’Connor, R. A., Stervbo, U., Hilgenberg, E., Ries, S., Dang, V. D., Jaimes, Y., Daridon, C., et al. (2014) · Nature · doi:10.1038/nature12979 · Cited by 1,048
Mizoguchi, A., Mizoguchi, E., Takedatsu, H., Blumberg, R. S., & Bhan, A. K. (2002) · Immunity · doi:10.1016/s1074-7613(02)00274-1 · Cited by 978
Prevention of Arthritis by Interleukin 10–producing B Cells
Mauri, C., Gray, D., Mushtaq, N., & Londei, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021293 · Cited by 860
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
de Visser, K. E., Korets, L. V., & Coussens, L. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.014 · Cited by 715
Flores-Borja, F., Bosma, A., Ng, D., Reddy, V., Ehrenstein, M. R., Isenberg, D. A., & Mauri, C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005407 · Cited by 688
Olkhanud, P. B., Damdinsuren, B., Bodogai, M., Gress, R. E., Sen, R., Wejksza, K., Malchinkhuu, E., Wersto, R. P., & Biragyn, A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4316 · Cited by 684
van de Veen, W., Stanic, B., Yaman, G., Wawrzyniak, M., Söllner, S., Akdis, D. G., Rückert, B., Akdis, C. A., & Akdis, M. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.014 · Cited by 652
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions
Yoshizaki, A., Miyagaki, T., DiLillo, D. J., Matsushita, T., Horikawa, M., Kountikov, E. I., Spolski, R., Poe, J. C., Leonard, W. J., & Tedder, T. F. (2012) · Nature · doi:10.1038/nature11501 · Cited by 634
B-cell biology and development
Pieper, K., Grimbacher, B., & Eibel, H. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.01.046 · Cited by 615
Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung Cancer
Al-Shibli, K. I., Donnem, T., Al-Saad, S., Persson, M., Bremnes, R. M., & Busund, L.-T. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0133 · Cited by 614
Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy
Shalapour, S., Font-Burgada, J., Di Caro, G., Zhong, Z., Sanchez-Lopez, E., Dhar, D., Willimsky, G., Ammirante, M., Strasner, A., Hansel, D. E., et al. (2015) · Nature · doi:10.1038/nature14395 · Cited by 611
FcRγ Activation Regulates Inflammation-Associated Squamous Carcinogenesis
Andreu, P., Johansson, M., Affara, N. I., Pucci, F., Tan, T., Junankar, S., Korets, L., Lam, J., Tawfik, D., DeNardo, D. G., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.019 · Cited by 590
Novel Suppressive Function of Transitional 2 B Cells in Experimental Arthritis
Evans, J. G., Chavez-Rueda, K. A., Eddaoudi, A., Meyer-Bahlburg, A., Rawlings, D. J., Ehrenstein, M. R., & Mauri, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7868 · Cited by 570
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
Matsumoto, M., Baba, A., Yokota, T., Nishikawa, H., Ohkawa, Y., Kayama, H., Kallies, A., Nutt, S. L., Sakaguchi, S., Takeda, K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.016 · Cited by 556
Nielsen, J. S., Sahota, R. A., Milne, K., Kost, S. E., Nesslinger, N. J., Watson, P. H., & Nelson, B. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0234 · Cited by 553
Allman, D., & Pillai, S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.03.014 · Cited by 536
Antibody-independent functions of B cells: a focus on cytokines
Shen, P., & Fillatreau, S. (2015) · Nature Reviews Immunology · doi:10.1038/nri3857 · Cited by 508
Yanaba, K., Bouaziz, J.-D., Matsushita, T., Tsubata, T., & Tedder, T. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900270 · Cited by 503
Carter, N. A., Vasconcellos, R., Rosser, E. C., Tulone, C., Muñoz-Suano, A., Kamanaka, M., Ehrenstein, M. R., Flavell, R. A., & Mauri, C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100284 · Cited by 476
Peripheral development of B cells in mouse and man
Carsetti, R., Rosado, M. M., & Wardmann, H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.0109.x · Cited by 473
Ding, Q., Yeung, M., Camirand, G., Zeng, Q., Akiba, H., Yagita, H., Chalasani, G., Sayegh, M. H., Najafian, N., & Rothstein, D. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46274 · Cited by 462
DiLillo, D. J., Matsushita, T., & Tedder, T. F. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05137.x · Cited by 432
B cells inhibit induction of T cell-dependent tumor immunity
Qin, Z., Richter, G., Schüler, T., Ibe, S., Cao, X., & Blankenstein, T. (1998) · Nature Medicine · doi:10.1038/nm0598-627 · Cited by 419
Tian, J., Zekzer, D., Hanssen, L., Lu, Y., Olcott, A., & Kaufman, D. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.2.1081 · Cited by 412
Spencer, J., Perry, M. E., & Dunn-Walters, D. K. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01308-5 · Cited by 407
Weill, J.-C., Weller, S., & Reynaud, C.-A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132607 · Cited by 405
PD-L1hi B cells are critical regulators of humoral immunity
Khan, A. R., Hams, E., Floudas, A., Sparwasser, T., Weaver, C. T., & Fallon, P. G. (2015) · Nature Communications · doi:10.1038/ncomms6997 · Cited by 387
B-cell suppression of delayed hypersensitivity reactions
KATZ, S. I., PARKER, D., & TURK, J. L. (1974) · Nature · doi:10.1038/251550a0 · Cited by 370
Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells
Lindner, S., Dahlke, K., Sontheimer, K., Hagn, M., Kaltenmeier, C., Barth, T. F. E., Beyer, T., Reister, F., Fabricius, D., Lotfi, R., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3450 · Cited by 363
DiLillo, D. J., Yanaba, K., & Tedder, T. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903009 · Cited by 359
Xiao, X., Lao, X.-M., Chen, M.-M., Liu, R.-X., Wei, Y., Ouyang, F.-Z., Chen, D.-P., Zhao, X.-Y., Zhao, Q., Li, X.-F., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-1408 · Cited by 352
IL-10–Producing Regulatory B Cells in the Pathogenesis of Chronic Hepatitis B Virus Infection
Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., Chen, A., Blair, P., Dusheiko, G., Gill, U., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103139 · Cited by 339
Inhibitory Effects of B Cells on Antitumor Immunity
Inoue, S., Leitner, W. W., Golding, B., & Scott, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3766 · Cited by 337
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis
Schioppa, T., Moore, R., Thompson, R. G., Rosser, E. C., Kulbe, H., Nedospasov, S., Mauri, C., Coussens, L. M., & Balkwill, F. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100994108 · Cited by 328
Kessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E., & Toubi, E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.018 · Cited by 295
Blair, P. A., Chavez-Rueda, K. A., Evans, J. G., Shlomchik, M. J., Eddaoudi, A., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803052 · Cited by 291
Carter, N. A., Rosser, E. C., & Mauri, C. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3736 · Cited by 284
B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo
Moulin, V., Andris, F., Thielemans, K., Maliszewski, C., Urbain, J., & Moser, M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.475 · Cited by 261
IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro
Bouaziz, J., Calbo, S., Maho‐Vaillant, M., Saussine, A., Bagot, M., Bensussan, A., & Musette, P. (2010) · European Journal of Immunology · doi:10.1002/eji.201040673 · Cited by 237
Shah, S., Divekar, A. A., Hilchey, S. P., Cho, H.-M., Newman, C. L., Shin, S.-U., Nechustan, H., Challita-Eid, P. M., Segal, B. M., Yi, K. H., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21177 · Cited by 227
Minard-Colin, V., Xiu, Y., Poe, J. C., Horikawa, M., Magro, C. M., Hamaguchi, Y., Haas, K. M., & Tedder, T. F. (2008) · Blood · doi:10.1182/blood-2008-01-135160 · Cited by 218
Khoder, A., Sarvaria, A., Alsuliman, A., Chew, C., Sekine, T., Cooper, N., Mielke, S., de Lavallade, H., Muftuoglu, M., Fernandez Curbelo, I., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571125 · Cited by 210
Self-citationBosma, A., Abdel-Gadir, A., Isenberg, D. A., Jury, E. C., & Mauri, C. (2012) · Immunity · doi:10.1016/j.immuni.2012.02.008 · Cited by 209
Suppression, subversion and escape: the role of regulatory T cells in cancer progression
Oleinika, K., Nibbs, R. J., Graham, G. J., & Fraser, A. R. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04657.x · Cited by 198
Knippenberg, S., Peelen, E., Smolders, J., Thewissen, M., Menheere, P., Cohen Tervaert, J. W., Hupperts, R., & Damoiseaux, J. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.08.019 · Cited by 195
Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice
Horikawa, M., Minard-Colin, V., Matsushita, T., & Tedder, T. F. (2011) · Journal of Clinical Investigation · doi:10.1172/jci59266 · Cited by 191
Neta, R., & Salvin, S. B. (1974) · The Journal of Immunology · doi:10.4049/jimmunol.113.6.1716 · Cited by 178
CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease
de Masson, A., Bouaziz, J.-D., Le Buanec, H., Robin, M., O’Meara, A., Parquet, N., Rybojad, M., Hau, E., Monfort, J.-B., Branchtein, M., et al. (2015) · Blood · doi:10.1182/blood-2014-09-599159 · Cited by 174
Maseda, D., Smith, S. H., DiLillo, D. J., Bryant, J. M., Candando, K. M., Weaver, C. T., & Tedder, T. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102500 · Cited by 174
Zhou, X., Su, Y.-X., Lao, X.-M., Liang, Y.-J., & Liao, G.-Q. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.003 · Cited by 172
NK- and B-Cell Infiltration Correlates With Worse Outcome in Metastatic Ovarian Carcinoma
Dong, H. P., Elstrand, M. B., Holth, A., Silins, I., Berner, A., Trope, C. G., Davidson, B., & Risberg, B. (2006) · American Journal of Clinical Pathology · doi:10.1309/15b6-6dqm-fyym-78cj · Cited by 165
Wang, W., Yuan, X.-L., Chen, H., Xie, G.-H., Ma, Y., Zheng, Y., Zhou, Y., & Shen, L.-S. (2015) · Oncotarget · doi:10.18632/oncotarget.5588 · Cited by 165
B Cells Promote Tumor Progression via STAT3 Regulated-Angiogenesis
Yang, C., Lee, H., Pal, S., Jove, V., Deng, J., Zhang, W., Hoon, D. S. B., Wakabayashi, M., Forman, S., & Yu, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064159 · Cited by 164
B10 cell regulation of health and disease
Candando, K. M., Lykken, J. M., & Tedder, T. F. (2014) · Immunological Reviews · doi:10.1111/imr.12176 · Cited by 163
Regulatory B cells accelerate hepatocellular carcinoma progression via CD40/CD154 signaling pathway
Shao, Y., Lo, C. M., Ling, C. C., Liu, X. B., Ng, K. T.-P., Chu, A. C. Y., Ma, Y. Y., Li, C. X., Fan, S. T., & Man, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.026 · Cited by 158
Jahrsdörfer, B., Blackwell, S. E., Wooldridge, J. E., Huang, J., Andreski, M. W., Jacobus, L., Taylor, C. M., & Weiner, G. J. (2006) · Blood · doi:10.1182/blood-2006-03-014001 · Cited by 156
Kaku, H., Cheng, K. F., Al‐Abed, Y., & Rothstein, T. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400336 · Cited by 156
Rafei, M., Hsieh, J., Zehntner, S. P., Li, M., Forner, K., Birman, E., Boivin, M., Young, Y. K., Perreault, C., & Galipeau, J. (2009) · Nature Medicine · doi:10.1038/nm.2003 · Cited by 150
Zhang, C., Xin, H., Zhang, W., Yazaki, P. J., Zhang, Z., Le, K., Li, W., Lee, H., Kwak, L. W., Forman, S. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.003 · Cited by 148
Phenotypic and functional characteristics of CD39highhuman regulatory B cells (Breg)
Figueiró, F., Müller, L., Funk, S., Jackson, E. K., Battastini, A. M. O., & Whiteside, T. L. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1082703 · Cited by 147
Maseda, D., Candando, K. M., Smith, S. H., Kalampokis, I., Weaver, C. T., Plevy, S. E., Poe, J. C., & Tedder, T. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300649 · Cited by 144
Bodogai, M., Lee-Chang, C., Wejksza, K., Lai, J., Merino, M. J., Wersto, R. P., Gress, R. E., Chan, A. C., Hesdorffer, C., & Biragyn, A. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4184 · Cited by 144
B cell-regulated immune responses in tumor models and cancer patients
Fremd, C., Schütz, F., Sohn, C., Beckhove, P., & Domschke, C. (2013) · OncoImmunology · doi:10.4161/onci.25443 · Cited by 143
Activation of Marginal Zone B Cells from Lupus Mice with Type A(D) CpG-Oligodeoxynucleotides
Brummel, R., & Lenert, P. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2429 · Cited by 142
Li, Q., Teitz‐Tennenbaum, S., Donald, E. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803773 · Cited by 140
Barberá‐Guillem, E., Nelson, M. B., Barr, B. L., Nyhus, J. K., May, K. F., Feng, L., & Sampsel, J. W. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/pl00006672 · Cited by 138
Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients
Wei, X. L., Jin, Y., Tian, Y., Zhang, H., Wu, J., Lü, W., & Lu, X. (2015) · Tumor Biology · doi:10.1007/s13277-015-4538-0 · Cited by 137
Siewe, B. T., Stapleton, J. T., Martinson, J., Keshavarzian, A., Kazmi, N., Demarais, P., French, A. L., & LANDAY, A. L. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912436 · Cited by 133
Zhang, Y. X., Morgan, R., Chen, C., Cai, Y., Clark, E., Khan, W. N., Shin, S.-U., Cho, H.-M., Bayati, A. A., Pimentel, A., et al. (2016) · International Immunology · doi:10.1093/intimm/dxw007 · Cited by 131
Marginal Zone B Cells Regulate Antigen-Specific T Cell Responses during Infection
Bankoti, R., Gupta, K., Levchenko, A., & Stäger, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102880 · Cited by 126
Transcriptomics Identify CD9 as a Marker of Murine IL-10-Competent Regulatory B Cells
Sun, J., Wang, J., Pefanis, E., Chao, J. L., Rothschild, G., Tachibana, I., Chen, J. K., Ivanov, I. I., Rabadán, R., Takeda, Y., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.070 · Cited by 120
Benedict, C., Brytting, M., Markström, A., Broman, J.-E., & Schiöth, H. B. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-1 · Cited by 119
Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer
Lundgren, S., Berntsson, J., Nodin, B., Micke, P., & Jirström, K. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0232-0 · Cited by 118
Kemp, T. J., Moore, J. M., & Griffith, T. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.892 · Cited by 115
Nedergaard, B. S., Ladekarl, M. B., Nyengaard, J. R., & Nielsen, K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.089 · Cited by 115
Wejksza, K., Lee-Chang, C., Bodogai, M., Bonzo, J. A., Gonzalez, F. J., Lehrmann, E., Becker, K. G., & Biragyn, A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201920 · Cited by 113
Sarvaria, A., Başar, R., Mehta, R. S., Shaim, H., Müftüoğlu, M., Khoder, A., Sekine, T., Gokdemir, E., Kondo, K., Marín, D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-695122 · Cited by 107
Self-citationGarraud, O., Borhis, G., Badr, G., Degrelle, S. A., Pozzetto, B., Cognasse, F., & Richard, Y. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-63 · Cited by 105
Zhang, L., Tai, Y.-T., Ho, M., Xing, L., Chauhan, D., An, G., Qiu, L., & Anderson, K. C. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.24 · Cited by 87
B cells and their mediators as targets for therapy in solid tumors
Gunderson, A. J., & Coussens, L. M. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.03.005 · Cited by 82
Zhang, Y., Eliav, Y., Shin, S.-U., Schreiber, T. H., Podack, E. R., Tadmor, T., & Rosenblatt, J. D. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1313-6 · Cited by 80
Regulatory B cells preferentially accumulate in tumor-draining lymph nodes and promote tumor growth
Ganti, S. N., Albershardt, T. C., Iritani, B. M., & Ruddell, A. (2015) · Scientific Reports · doi:10.1038/srep12255 · Cited by 77
Glioma cell-derived placental growth factor induces regulatory B cells
Han, S. I., Feng, S., Ren, M., Ma, E., Wang, X., Xu, L., & Xu, M. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.005 · Cited by 75
Sorrentino, R., Morello, S., Forte, G., Montinaro, A., Vita, G. D., Luciano, A., Palma, G., Arra, C., Maiolino, P., Adcock, I. M., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1738oc · Cited by 71
Tumor‐associated immunoglobulins. enhancement of syngeneic tumors by igg2‐containing tumor eluates
Ran, M., & Witz, I. P. (1972) · International Journal of Cancer · doi:10.1002/ijc.2910090126 · Cited by 64
Domschke, C., Schütz, F., Ge, Y., Seibel, T., Falk, C. S., Brors, B., Vlodavsky, I., Sommerfeldt, N., Sinn, H., Kühnle, M.-C., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1627 · Cited by 63
Aklilu, M., Stadler, W. M., Markiewicz, M. A., Vogelzang, N. J., Mahowald, M. B., Johnson, M. B., & Gajewski, T. F. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh280 · Cited by 62
Feedback suppression of the immune response in vivo
Shimamura, T., Hashimoto, K., & Sasaki, S. (1982) · Cellular Immunology · doi:10.1016/0008-8749(82)90093-4 · Cited by 58
Siewe, B. T., Wallace, J., Rygielski, S., Stapleton, J. T., Martin, J. N., Deeks, S. G., & LANDAY, A. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092934 · Cited by 48
Qian, L., Bian, G., Zhou, Y., Wang, Y., Hu, J., Liu, X., & Xu, Y. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.52840 · Cited by 44
Cohen, S. B., Smith, N. L., McDougal, C. E., Pepper, M., Shah, S. M., Yap, G. S., Acha‐Orbea, H., Jiang, A., Clausen, B. E., Rudd, B. D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1402453 · Cited by 41
Park, J. M., Terabe, M., Steel, J. C., Forni, G., Sakai, Y., Morris, J. C., & Berzofsky, J. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5688 · Cited by 41
Kurosaki, T. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00946.x · Cited by 34
Naradikian, M. S., Scholz, J. L., Oropallo, M. A., & Cancro, M. P. (2013) · Milestones in drug therapy · doi:10.1007/978-3-0348-0706-7_2 · Cited by 12
Increased percentage of B cells in patients with more advanced hepatocellular carcinoma
Lin, J.-C., Shih, Y., Chien, P.-J., Liu, C., Lee, J.-J., Liu, T.-P., Ko, W.-C., & Shih, C.-M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.10.003 · Cited by 12
Cited by
B cells and tertiary lymphoid structures promote immunotherapy response
Helmink, B. A., Reddy, S. M., Gao, J., Zhang, S., Basar, R., Thakur, R., Yizhak, K., Sade-Feldman, M., Blando, J., Han, G., et al. (2020) · Nature · doi:10.1038/s41586-019-1922-8 · Cited by 2,731
“Tumor infiltrating B lymphocytes have been identified, yet their overall functional role in cancer is incompletely understood 14,15,19-24 – with some studies suggesting that they are tumor-promoting while others show a positive association with improved cancer outcomes, particularly when they are…”
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy
Bruni, D., Angell, H. K., & Galon, J. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0285-7 · Cited by 1,586
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
Seidel, J. A., Otsuka, A., & Kabashima, K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00086 · Cited by 1,360
Metadata
- Authors
- Sarvaria, A., Madrigal, J. A., & Saudemont, A.
- Venue
- Cellular & Molecular Immunology
- Published
- 2017-06-19
- Volume
- 14
- Issue
- 8
- Pages
- 662-674
- ISSN
- 1672-7681 (ISSN-L)
- 2042-0226
- OpenAlex
- W2698159436
- Cited by
- 630
- References
- 109
- FWCI
- 16.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.